Abstract
To the Editor: We read with great interest the paper of Kamel et al,1 which analyzed the cost-effectiveness of prolonged Holter monitoring for secondary stroke prevention and found net costs of $13.00/quality-adjusted life year gained. We, however, would like to bring to attention 2 factors that may further increase the cost-effectiveness of prolonged Holter monitoring:
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
